Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
482.3 USD | +1.62% | +2.35% | +18.54% |
07-02 | FDA Accepts Vertex Pharmaceuticals' New-Drug Application for Combination Therapy to Treat Cystic Fibrosis | MT |
07-02 | Vertex Gets Speedy FDA Review of Vanza Triple Cystic Fibrosis Therapy | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.54% | 122B | |
+19.86% | 112B | |
-23.99% | 19.33B | |
-18.45% | 16.17B | |
-18.87% | 15.6B | |
-49.33% | 14.65B | |
+57.48% | 14.34B | |
+7.46% | 14B | |
+126.70% | 11.29B | |
+153.62% | 9.73B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated - Special Call